HCM
CELG

HMS Capital Management’s Celgene Corp CELG Stock Holding History

HMS Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-400
Closed -$37K – 316
2019
Q2 		$37K Buy
+400
New +$38K 0.02% 230
2018
Q4 		– Sell
-400
Closed -$36K – 232
2018
Q3 		$36K Buy
+400
New +$35.3K 0.02% 202
2017
Q4 		– Sell
-900
Closed -$131K – 163
2017
Q3 		$131K Buy
+900
New +$123K 0.11% 118

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HMS Capital Management's CELG Position: Q3 2019 in Review

HMS Capital Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 470 shares — an estimated $43K sold.

HMS Capital Management first reported a position in CELG in Q3 2017 and held it in 4 quarters. The position peaked at $1.35M in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • HMS Capital Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • HMS Capital Management sold 470 Celgene Corp shares in Q3 2019, an estimated $43K.
  • HMS Capital Management first reported a position in Celgene Corp in Q3 2017 and held it in 4 quarters.
  • HMS Capital Management's Celgene Corp position peaked at $1.35M in Q3 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on HMS Capital Management's 13F filing for Q3 2019, filed 15 Oct 2019.